SuperworthDiaMedica Therapeutics market cap DMAC
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $470.2M
- Highest close in our data
- $489M
- Dec 2025
DiaMedica Therapeutics is worth $470.2M at the close on Oct 23, 2026, at $8.72 a share.
That is up 32% over the last year and up 534% over five years.
Its highest close in our data was $489M in Dec 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $470.2M | $303.9M | $470.2M | +10% |
| 2025 | $428.6M | $148.7M | $489M | +85% |
| 2024 | $231.3M | $82M | $274.1M | +115% |
| 2023 | $107.8M | $35.7M | $126.4M | +158% |
| 2022 | $41.8M | $29.9M | $94.9M | −58% |
| 2021 | $98.6M | $58.2M | $195.4M | −48% |
| 2020 | $190M | $31.3M | $190M | +222% |
| 2019 | $59.1M | $22.1M | $59.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest DiaMedica Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| DMACDiaMedica Therapeutics | $470.2M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| NATRNatures Sunshine Products | $213.8M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| Peer median | $597.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on DiaMedica Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.